India and the Patent Wars : Pharmaceuticals in the New Intellectual Property Regime / Murphy Halliburton.

By: Contributor(s): Material type: TextTextSeries: The culture and politics of health care work | Book collections on Project MUSEPublisher: Ithaca : ILR Press, an imprint of Cornell University Press, 2017Manufacturer: Baltimore, Md. : Project MUSE, 2018Copyright date: ©2017Description: 1 online resource (202 pages)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781501713989
Subject(s): Genre/Form: Online resources:
Contents:
The invention and expansion of intellectual property -- The new patent regime : the activists and their allies -- Ayurvedic dilemmas : innovation, ownership and resistance -- The Gilead model and the perspective of "big pharma" -- The view from Hyderabad : the "Indian" pharmaceutical industry and the new patent regime.
Summary: India and the Patent Wars contributes to an international debate over the costs of medicine and restrictions on access under stringent patent laws showing how activists and drug companies in low-income countries seize agency and exert influence over ...
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

The invention and expansion of intellectual property -- The new patent regime : the activists and their allies -- Ayurvedic dilemmas : innovation, ownership and resistance -- The Gilead model and the perspective of "big pharma" -- The view from Hyderabad : the "Indian" pharmaceutical industry and the new patent regime.

Open Access Unrestricted online access star

India and the Patent Wars contributes to an international debate over the costs of medicine and restrictions on access under stringent patent laws showing how activists and drug companies in low-income countries seize agency and exert influence over ...

Description based on print version record.

There are no comments on this title.

to post a comment.